142 related articles for article (PubMed ID: 30806479)
41. Study of volumetric and dosimetric changes during fractionated radiotherapy in head and neck cancers: A single centre experience.
Kumar V; Nautiyal V; Kant R; Gupta M; Bansal S; Ahmad M
J Cancer Res Ther; 2021; 17(1):235-241. PubMed ID: 33723161
[TBL] [Abstract][Full Text] [Related]
42. U-net architecture with embedded Inception-ResNet-v2 image encoding modules for automatic segmentation of organs-at-risk in head and neck cancer radiation therapy based on computed tomography scans.
Siciarz P; McCurdy B
Phys Med Biol; 2022 Jun; 67(11):. PubMed ID: 35134792
[No Abstract] [Full Text] [Related]
43. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
[TBL] [Abstract][Full Text] [Related]
44. Intraoperative cone-beam CT for guidance of head and neck surgery: Assessment of dose and image quality using a C-arm prototype.
Daly MJ; Siewerdsen JH; Moseley DJ; Jaffray DA; Irish JC
Med Phys; 2006 Oct; 33(10):3767-80. PubMed ID: 17089842
[TBL] [Abstract][Full Text] [Related]
45. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
[TBL] [Abstract][Full Text] [Related]
46. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
[No Abstract] [Full Text] [Related]
47. Dosimetric evaluation of synthetic CT for head and neck radiotherapy generated by a patch-based three-dimensional convolutional neural network.
Dinkla AM; Florkow MC; Maspero M; Savenije MHF; Zijlstra F; Doornaert PAH; van Stralen M; Philippens MEP; van den Berg CAT; Seevinck PR
Med Phys; 2019 Sep; 46(9):4095-4104. PubMed ID: 31206701
[TBL] [Abstract][Full Text] [Related]
48. Quantification of gross tumour volume changes between simulation and first day of radiotherapy for patients with locally advanced malignancies of the lung and head/neck.
Kishan AU; Cui J; Wang PC; Daly ME; Purdy JA; Chen AM
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):618-24. PubMed ID: 24942938
[TBL] [Abstract][Full Text] [Related]
49. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
50. Functional and biochemical changes in the thyroid gland following exposure to therapeutic doses of external beam radiotherapy in the head-and-neck cancer patients.
Randhawa AS; Yadav HP; Banipal RPS; Goyal G; Garg P; Marcus S
J Cancer Res Ther; 2021; 17(4):1025-1030. PubMed ID: 34528559
[TBL] [Abstract][Full Text] [Related]
51. Effect of CT contrast on volumetric arc therapy planning (RapidArc and helical tomotherapy) for head and neck cancer.
Liu AJ; Vora N; Suh S; Liu A; Schultheiss TE; Wong JY
Med Dosim; 2015; 40(1):32-6. PubMed ID: 25242679
[TBL] [Abstract][Full Text] [Related]
52. Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy.
Yip C; Thomas C; Michaelidou A; James D; Lynn R; Lei M; Guerrero Urbano T
Br J Radiol; 2014 Feb; 87(1034):20130532. PubMed ID: 24288402
[TBL] [Abstract][Full Text] [Related]
53. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Bollineni VR; Koole MJ; Pruim J; Brouwer CL; Wiegman EM; Groen HJ; Vlasman R; Halmos GB; Oosting SF; Langendijk JA; Widder J; Steenbakkers RJ
Radiother Oncol; 2014 Nov; 113(2):198-203. PubMed ID: 25434768
[TBL] [Abstract][Full Text] [Related]
54. Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy.
Li Y; Awan MJ; Chang T; Lavertu P; Zender C; Rezaee R; Fowler N; Wasman J; Avril NE; Chen N; Machtay M; Yao M
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):794-800. PubMed ID: 30680587
[TBL] [Abstract][Full Text] [Related]
55. Cross-institutional outcome prediction for head and neck cancer patients using self-attention neural networks.
Le WT; Vorontsov E; Romero FP; Seddik L; Elsharief MM; Nguyen-Tan PF; Roberge D; Bahig H; Kadoury S
Sci Rep; 2022 Feb; 12(1):3183. PubMed ID: 35210482
[TBL] [Abstract][Full Text] [Related]
56. Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.
Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Pareek M; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
Oral Oncol; 2019 Jul; 94():1-7. PubMed ID: 31178202
[TBL] [Abstract][Full Text] [Related]
57. Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients.
Dragan T; Beauvois S; Moreau M; Paesmans M; Vandekerkhove C; Cordier L; Van Gestel D
Oral Oncol; 2019 Nov; 98():132-140. PubMed ID: 31586895
[TBL] [Abstract][Full Text] [Related]
58. In vivo assessment of the safety of standard fractionation Temporally Feathered Radiation Therapy (TFRT) for head and neck squamous cell carcinoma: An R-IDEAL Stage 1/2a first-in-humans/feasibility demonstration of new technology implementation.
Parsai S; Qiu RLJ; Qi P; Sedor G; Fuller CD; Murray E; Majkszak D; Dorio N; Koyfman S; Woody N; Joshi N; Scott JG
Radiother Oncol; 2021 Oct; 163():39-45. PubMed ID: 34333086
[TBL] [Abstract][Full Text] [Related]
59. Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study.
Hay LK; Paterson C; McLoone P; Miguel-Chumacero E; Valentine R; Currie S; Grose D; Schipani S; Wilson C; Nixon I; James A; Duffton A
Tech Innov Patient Support Radiat Oncol; 2020 Jun; 14():21-29. PubMed ID: 32226833
[TBL] [Abstract][Full Text] [Related]
60. Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer.
Thomson DJ; Beasley WJ; Garcez K; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
Med Dosim; 2016; 41(2):154-8. PubMed ID: 26993081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
